跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,286 条关于
“GM1 gangliosidosis”
全部
1,286
临床试验
903
药物
267
机构
9
资讯
107
上个月
In Utero Gene Therapy Trial Targets GM1 Gangliosidosis Before Birth
去年
Azafaros' Nizubaglustat Gains Orphan Drug Designations, Phase 3 Trials to Start in 2025
3个月前
Azafaros Publishes Phase 2 RAINBOW Study Data for Nizubaglustat in GM2 Gangliosidosis and Niemann-Pick Type C Disease
10个月前
SylamoreBio Secures $3 Million NIH Grant to Develop Blood-Brain Barrier Therapy for Rare Neurodegenerative Disease
去年
Azafaros to Present at J.P. Morgan's 43rd Annual Healthcare Conference
7个月前
Azafaros to Present Phase 3 Nizubaglustat Data for Rare Lysosomal Storage Disorders at WORLDSymposium 2026
去年
2024 Breakthroughs and Setbacks in Lysosomal Disorder Gene Therapies
去年
Azafaros Secures €130M Funding to Advance Nizubaglustat into Phase III for Rare Lysosomal Storage Disorders
2年前
Gene Therapy Pioneer Jim Wilson Departs UPenn to Launch Two New Companies
去年
MEDIPAL Holdings and JCR Pharmaceuticals Partner on Novel GM2 Gangliosidosis Therapy JR-479
第 1 页,共 11 页
上一页
下一页